期刊
JOURNAL OF VIROLOGY
卷 76, 期 12, 页码 6408-6412出版社
AMER SOC MICROBIOLOGY
DOI: 10.1128/JVI.76.12.6408-6412.2002
关键词
-
类别
资金
- NIAID NIH HHS [AI48053, R01 AI048053] Funding Source: Medline
A neutralizing human monoclonal antibody, KZ52, protects guinea pigs from lethal Ebola Zaire virus challenge. Administration before or up to 1 h after challenge resulted in dose-dependent protection by the antibody. Interestingly, some antibody-treated animals survived despite developing high-level viremia, suggesting that the mechanism of protection by KZ52 may extend beyond reduction of viremia by virus neutralization. KZ52 is a promising candidate for immunoprophylaxis of Ebola virus infection.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据